Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Debt / NOTE 1.000%11/1
-
Number of holders
-
49
-
Total 13F principal, excl. options
-
207,530,234
-
Principal change
-
+14,711,624
-
Total reported value, excl. options
-
$210,897,141
-
Value change
-
+$12,815,532
-
Number of buys
-
16
-
Number of sells
-
-29
-
Price
-
$1.01
Significant Holders of ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 as of Q1 2020
59 filings reported holding 464337AJ3 - ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 as of Q1 2020.
ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 has 49 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $207,530,234 of principal
.
Largest 10 bondholders include TENOR CAPITAL MANAGEMENT Co., L.P. ($34,448,000 of principal), MACKAY SHIELDS LLC ($32,910,000 of principal), D. E. Shaw & Co., Inc. ($23,128,000 of principal), STATE STREET CORP ($15,740,000 of principal), SONORA INVESTMENT MANAGEMENT, LLC ($9,376,000 of principal), Man Group plc ($7,690,000 of principal), CSS LLC/IL ($7,500,000 of principal), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($7,000,000 of principal), FMR LLC ($6,945,000 of principal), and DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main ($5,700,000 of principal).
This table shows the top 49 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.